Last updated 13 days ago

Home-based Transcranial Direct Current Stimulation (tDCS) Compared to Duloxetine:On-inferiority Clinical Trial (FIBROSTIM)

610 patients around the world
Available in Brazil
Hospital de Clinicas de Porto Alegre
1Research sites
610Patients around the world

This study is for people with

Fibromyalgia

Requirements for the patient

To 75 Years
Female

Medical requirements

Woman aged between 18 and 75 years.
Right-handed.
Literate in reading and writing.
Clinical diagnosis of fibromyalgia based on the American College of Rheumatology (ACR) 2010-2016 criteria.
Numeric Pain Scale (NPS) score ≥ 4 on most days in the past 30 days.
Agree no changes in medication dosage during the treatment period (except for analgesics).
Able to swallow tablets.
Able to understand instructions for using tDCS at home.
Living more than 250 km from Porto Alegre.
Pregnancy.
Decompensated systemic diseases.
Chronic inflammatory rheumatologic diseases.
Untreated hypothyroidism.
Active cancer under treatment.
Alcohol or drug abuse in the past 6 months.
Decompensated psychiatric disorders with suicide risk and a defined plan.
Use of duloxetine at a dose > 60 mg/day.
Metal implants in the brain.
Implanted brain medical devices.
Cardiac pacemaker.
Cochlear implant.
Neurological disorders.
History of traumatic brain injury or neurosurgery.

Sites

Hospital de Clínicas de Porto Alegre
Rua Ramiro Barcelos, 2350, Av. Protásio Alves, 211 - Santa Cecília, Porto Alegre - RS, 90035-903
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy